Common and rare genetic risk factors for glaucoma

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 12, 2014, Pages

  Wang, Ryan ^a   Wiggs, Janey L ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CLOSED ANGLE GLAUCOMA; CONGENITAL GLAUCOMA; EPIGENETICS; ESTROGEN METABOLISM; EXTRACELLULAR MATRIX; GENE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLAUCOMA; HUMAN; LOW TENSION GLAUCOMA; OPEN ANGLE GLAUCOMA; OPTIC NERVE LESION; PHENOTYPE; PSEUDOEXFOLIATION; DOMINANT GENE; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; ONSET AGE; RECESSIVE GENE; RISK FACTOR;

AGE OF ONSET; EPIGENESIS, GENETIC; GENE-ENVIRONMENT INTERACTION; GENES, DOMINANT; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GLAUCOMA; GLAUCOMA, OPEN-ANGLE; HUMANS; RISK FACTORS;

EID: 84937550678     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a017244     Document Type: Article

References (109)

1. Abu A, Frydman M, Marek D, Pras E, Nir U, Reznik-Wolf H, Pras E. 2008. Deleterious mutations in the Zinc-Finger 469 gene cause brittle cornea syndrome. Am J Hum Genet 82: 1217-1222.
2. Acott TS, Kelley MJ. 2008. Extracellular matrix in the trabecular meshwork. Exp Eye Res 86: 543-561.
3. Adam MF, Belmouden A, Binisti P, Brézin AP, Valtot F, Béchetoille A, Dascotte JC, Copin B, Gomez L, Chaventré A, et al. 1997. Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet 6.12: 2091-2097.
4. Akarsu A, Nurten M, Erol Turacli S, Gulderen Aktan, Magda Barsoum-Homsy, Line Chevrette, B, Sitki Sayli, Mansoor Sarfarazi. 1996. A second locus (GLC3B) for primary congenital glaucoma (Buphthalmos) maps to the 1p36 region. Hum Mol Genet 5: 1199-1203.
5. Ali M, McKibbin M, Booth A, Parry DA, Jain P, Riazuddin SA, Hejtmancik JF, Khan SN, Firasat S, Shires M, et al, 2009. Null mutations in LTBP2 cause primary congenital glaucoma. Am J Hum Genet 84: 664-671.
6. Aponte EP, Diehl N, Mohney BG. 2010. Incidence and clinical characteristics of childhood glaucoma: A population-based study. Arch Ophthalmol 128: 478-482.
7. Aroca-Aguilar JD, Martínez-Redondo F, Sánchez-Sánchez F, Coca-Prados M, Escribano J. 2010. Functional role of proteolytic processing of recombinant myocilin in selfaggregation. Invest Ophthalmol Vis Sci 51: 72-78.
8. Aung T, Rezaie T, Okada K, Viswanathan AC, Child AH, Brice G, Bhattacharya SS, Lehmann OJ, Sarfarazi M, Hitchings RA. 2005. Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Invest Ophthalmol Vis Sci 46: 2816-2822.
9. Awadalla MS, Thapa SS, Hewitt AW, Burdon KP, Craig JE. 2013. Association of genetic variants with primary angle closure glaucoma in two different populations. PLoS ONE 8: e67903.
10. Axenovich T, Zorkoltseva I, Belonogova N, van Koolwijk LM, Borodin P, Kirichenko A, Babenko V, Ramdas WD, Amin N, Despriet DD, et al. 2011. Linkage and association analyses of glaucoma related traits in a large pedigree from a Dutch genetically isolated population. J Med Genet 48: 802-809.
11. Bejjani BA, Stockton DW, Lewis RA, Tomey KF, Dueker DK, Jabak M, Astle WF, Lupski JR. 2000. Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus. Hum Mol Genet 9: 367-374.
12. Blanco-Marchite C, Sánchez-Sánchez F, López-Garrido MP, Iñigez-de-Onzoño M, López-Martínez F, López-Sánchez E, Alvarez L, Rodríguez-Calvo PP, Méndez-Hernández C, Fernández-Vega L, et al. 2011. WDR36 and P53 gene variants and susceptibility to primary open-angle glaucoma: Analysis of gene-gene interactions. Invest Ophthalmol Vis Sci 52: 8467-8478.
13. Burdon KP, Macgregor S, Hewitt AW, Sharma S, Chidlow G, Mills RA, Danoy P, Casson R, Viswanathan AC, Liu JZ, et al. 2011. Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet 43: 574-578.
14. Chakrabarti S, Ghanekar Y, Kaur K, Kaur I, Mandal AK, Rao KN, Parikh RS, Thomas R, Majumder PP. 2010. A polymorphism in the CYP1B1 promoter is functionally associated with primary congenital glaucoma. Hum Mol Genet 19: 4083-4090.
15. Charlesworth J, Kramer PL, Dyer T, Diego V, Samples JR, Craig JE, Mackey DA, Hewitt AW, Blangero J, Wirtz MK. 2010. The path to open-angle glaucoma gene discovery: Endophenotypic status of intraocular pressure, cup-todisc ratio, and central corneal thickness. Invest Ophthalmol Vis Sci 51: 3509-3514.
16. Chen H, Lun Y, Ovchinnikov D, Kokubo H, Oberg KC, Pepicelli CV, Can L, Lee B, Johnson RL. 1998. Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat Genet 19: 51-55.
17. Choudhary D, Jansson I, Sarfarazi M, Schenkman JB. 2008. Characterization of the biochemical and structural phenotypes of four CYP1B1 mutations observed in individuals with primary congenital glaucoma. Pharmacogenet Genomics 18: 665-676.
18. Choudhary D, Jansson I, Schenkman JB. 2009. CYP1B1, a developmental gene with a potential role in glaucoma therapy. Xenobiotica 39: 606-615.
19. Cooke Bailey JN, Sobrin L, Pericak-Vance MA, Haines JL, Hammond CJ, Wiggs JL. 2013. Advances in the genomics of common eye diseases. Hum Mol Genet 22: R59-R65.
20. Crawford Downs J, Roberts MD, Sigal IA. 2011. Glaucomatous cupping of the lamina cribrosa: A review of the evidence for active progressive remodeling as a mechanism. Exp Eye Res 93: 133-140.
21. Dreyer SD, Zhou G, Baldini A, Winterpacht A, Zabel B, Cole W, Johnson RL, Lee B. 1998. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 19: 47-50.
22. Fan BJ, Ko WC, Wang DY, Canlas O, Ritch R, Lam DS, Pang CP. 2007. Fine mapping of new glaucoma locus GLC1M and exclusion of neuregulin 2 as the causative gene. Mol Vis 13: 779-784.
23. Fan BJ, Wang DY, Pasquale LR, Haines JL, Wiggs JL. 2011. Genetic variants associated with optic nerve vertical cupto-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population. Invest Ophthalmol Vis Sci 52: 1788-1792.
24. Fingert JH, Héon E, Liebmann JM, Yamamoto T, Craig JE, Rait J, Kawase K, Hoh ST, Buys YM, Dickinson J, et al. 1999. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet 8: 899-905.
25. Fingert JH, Robin AL, Stone JL, Roos BR, Davis LK, Scheetz TE, Bennett SR, Wassink TH, Kwon YH, Alward WL, et al. 2011. Copy number variations on chromosome 12q14 in patients with normal tension glaucoma. Hum Mol Genet 20: 2482-2494.
26. Fuchshofer R. 2011. The pathogenic role of transforming growth factor-b2 in glaucomatous damage to the optic nerve head. Exp Eye Res 93: 165-169.
27. Fuchshofer R, Tamm ER. 2012. The role of TGF-b in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res 347: 279-290.
28. Gould DB, John SW. 2002. Anterior segment dysgenesis and the developmental glaucomas are complex traits. Hum Mol Genet 11: 1185-1193.
29. Gould DB, Mears AJ, Pearce WG, Walter MA. 1997. Autosomal dominant Axenfeld-Rieger anomaly maps to 6p25. Am J Hum Genet 61: 765-768.
30. Haji-Seyed-Javadi R, Jelodari-Mamaghani S, Paylakhi SH, Yazdani S, Nilforushan N, Fan JB, Klotzle B, Mahmoudi MJ, Ebrahimian MJ, Chelich N, et al. 2012. LTBP2 mutations cause Weill-Marchesani and Weill-Marchesanilike syndrome and affect disruptions in the extracellular matrix. Hum Mutat 33: 1182-1187.
31. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF. 2000. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 60: 3440-3444.
32. Hingorani M, Williamson KA, Moore AT, Van Heyningen V. 2009. Detailed ophthalmologic evaluation of 43 individuals with PAX6 mutations. Invest Ophthalmol Vis Sci 14: 2581-2590.
33. Jelodari-Mamaghani S, Haji-Seyed-Javadi R, Suri F, Nilforushan N, Yazdani S, Kamyab K, Elahi E. 2013. Contribution of the latent transforming growth factor-b binding protein 2 gene to etiology of primary open angle glaucoma and pseudoexfoliation syndrome. Mol Vis 19: 333-347.
34. Joe MK, Sohn S, Hur W, Moon Y, Choi YR, Kee C. 2003. Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells. Biochem Biophys Res Commun 312: 592-600.
35. Johnson AT, Richards JE, Boehnke M, Stringham HM, Herman SB, Wong DJ, Lichter PR. 1996. Clinical phenotype of juvenile-onset primary open-angle glaucoma linked to chromosome 1q. Ophthalmology 103: 808-814.
36. Jonas JB, Wang N. 2013. Cerebrospinal fluid pressure and glaucoma. J Ophthalmic Vis Res 8: 257-263.
37. Kang JH, Wiggs JL, Rosner BA, Hankinson SE, Abdrabou W, Fan BJ, Haines J, Pasquale LR. 2010. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: Interactions with sex and postmenopausal hormone use. Invest Ophthalmol Vis Sci 51: 971-979.
38. Kang JH, Loomis S, Wiggs JL, Stein JD, Pasquale LR. 2012. Demographic and geographic features of exfoliation glaucoma in 2 United States-based prospective cohorts. Ophthalmology 119: 27-35.
39. Kang JH, Wiggs JL, Pasquale LR. 2013. A nested case control study of plasma ICAM-1, E-selectin and TNF receptor 2 levels, and incident primary open-angle glaucoma. Invest Ophthalmol Vis Sci 54: 1797-1804.
40. Kim BS, Savinova OV, Reedy MV, Martin J, Lun Y, Gan L, Smith RS, Tomarev SI, John SW, Johnson RL. 2001. Targeted disruption of the myocilin gene (Myoc) suggests that human glaucoma-causing mutations are gain of function. Mol Cell Biol 21: 7707-7713.
41. Kubota R, Noda S, Wang Y, Minoshima S, Asakawa S, Kudoh J, Mashima Y, Oguchi Y, Shimizu N. 1997. A novel myosin-like protein (myocilin) expressed in the connecting cilium of the photoreceptor: Molecular cloning, tissue expression, and chromosomal mapping. Genomics 41: 360-369.
42. Lam DS, Leung YF, Chua JK, Baum L, Fan DS, Choy KW, Pang CP. 2000. Truncations in the TIGR gene in individuals with and without primary open-angle glaucoma. Invest Ophthalmol Vis Sci 41: 1386-1391.
43. Lim SH, Tran-Viet KN, Yanovitch TL, Freedman SF, Klemm T, Call W, Powell C, Ravichandran A, Metlapally R, Nading EB, et al. 2013. CYP1B1, MYOC, and LTBP2 mutations in primary congenital glaucoma patients in the United States. Am J Ophthalmol 155: 508-517.
44. Liton PB, Liu X, Stamer WD, Challa P, Epstein DL, Gonzalez P. 2005. Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter. Invest Ophthalmol Vis Sci 46: 183-190.
45. Loomis SJ, Kang JH, Weinreb RN, Yaspan BL, Cooke Bailey JN, Gaasterland D, Gaasterland T, Lee RK, Lichter PR, Budenz DL, Liu Y, et al. 2014. Association of CAV1/CAV2 genomic variants with primary open-angle glaucoma overall and by gender and pattern of visual field loss. Ophthalmology 121: 508-516.
46. Lu Y, Vitart V, Burdon KP, Khor CC, Bykhovskaya Y, Mirshahi A, Hewitt AW, Koehn D, Hysi PG, Ramdas WD, et al. 2013. Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus. Nat Genet 45: 155-163.
47. Macgregor S, Hewitt AW, Hysi PG, Ruddle JB, Medland SE, Henders AK, Gordon SD, Andrew T, McEvoy B, Sanfilippo PG, et al. 2010. Genome-wide association identifies ATOH7 as a major gene determining human optic disc size. Hum Mol Genet 19: 2716-2724.
48. Manolio TA, Brooks LD, Collins FS. 2008. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118: 1590-1605.
49. Mears AJ, Jordan T, Mirzayans F, Dubois S, Kume T, Parlee M, Ritch R, Koop B, Kuo WL, Collins C, et al. 1998. Mutations of the Forkhead/Winged-Helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet 63: 1316-1328.
50. Michels-Rautenstrauss KG, Mardin CY, Zenker M, Jordan N, Gusek-Schneider GC, Rautenstrauss BW. 2001. Primary congenital glaucoma: Three case reports on novel mutations and combinations of mutations in the GLC3A (CYP1B1) gene. J Glaucoma 10: 354-357.
51. Mimiwati Z, Mackey DA, Craig JE, Mackinnon JR, Rait JL, Liebelt JE, Ayala-Lugo R, Vollrath D, Richards JE. 2006. Nail-patella syndrome and its association with glaucoma: A review of eight families. Br J Ophthalmol 90: 1505-1509.
52. Minegishi Y, Iejima D, Kobayashi H, Chi ZL, Kawase K, Yamamoto T, Seki T, Yuasa S, Fukuda K, Iwata T. 2013. Enhanced optineurin E50K-TBK1 interaction evokes protein insolubility and initiates familial primary openangle glaucoma. Hum Mol Genet 22: 3559-3567.
53. Morton S, Hesson L, Peggie M, Cohen P. 2008. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett 582: 997-1002.
54. Munaut C, Lambert V, Noël A, Frankenne F, Deprez M, Foidart JM, Rakic JM. 2001. Presence of oestrogen receptor type b in human retina. Br J Ophthalmol 85: 877-882.
55. Narooie-Nejad M, Paylakhi SH, Shojaee S, Fazlali Z, Kanavi MR, Nilforushan N, Yazdani S, Babrzadeh F, Suri F, Ronaghi M, et al. 2009. Loss of function mutations in the gene encoding latent transforming growth factor b binding protein 2, LTBP2, cause primary congenital glaucoma. Hum Mol Genet 18: 3969-3977.
56. Naumann GO, Schlötzer-Schrehardt U, Kuchle M. 1998. Pseudoexfoliation syndrome for the comprehensive ophthalmologist: Intraocular and systemic manifestations. Ophthalmology 105: 951-968.
57. Pang CP, Fan BJ, Canlas O, Wang DY, Dubois S, Tam PO, Lam DS, Raymond V, Ritch R. 2006. A genome-wide scan maps a novel juvenile-onset primary open angle glaucoma locus to chromosome 5q. Mol Vis 12: 85-92.
58. Pasquale LR, Kang JH. 2009. Lifestyle, nutrition and glaucoma. J Glaucoma 18: 423.
59. Pasquale LR, Loomis SJ, Weinreb RN, Kang JH, Yaspan BL, Bailey JC, Gaasterland D, Gaasterland T, Lee RK, Scott WK, et al. 2013. Estrogen pathway polymorphisms in relation to primary open angle glaucoma: An analysis accounting for gender from the United States. Mol Vis 19: 1471-1481.
60. Ramdas WD, van Koolwijk LM, Ikram MK, Jansonius NM, de Jong PT, Bergen AA, Isaacs A, Amin N, Aulchenko YS, Wolfs RC, et al. 2010. A genome-wide association study of optic disc parameters. PLoS Genet 6: e1000978.
61. Ramdas WD, van Koolwijk LM, Ikram MK, Jansonius NM, de Jong PT, Bergen AA, Isaacs A, Amin N, Aulchenko YS, Wolfs RC, et al. 2011. Common genetic variants associated with open-angle glaucoma. Hum Mol Genet 20: 2464-2471.
62. Reis LM, Tyler RC, Volkmann Kloss BA, Schilter KF, Levin AV, Lowry RB, Zwijnenburg PJ, Stroh E, Broeckel U, Murray JC, et al. 2012. PITX2 and FOXC1 spectrum of mutations in ocular syndromes. Eur J Hum Genet 20: 1224-1233.
63. Rezaie T, Child A, Hitchings R, Brice G, Miller L, CocaPrados M, Héon E, Krupin T, Ritch R, Kreutzer D, et al. 2002. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295: 1077-1079.
64. Richards AJ, Yates JR, Williams R, Payne SJ, Pope FM, Scott JD, Snead MP. 1996. A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in a1(XI) collagen. Hum Mol Genet 5: 1339-1343.
65. Riise R, Storhaug K, Brøndum-Nielsen K. 2001. Rieger syndrome is associated with PAX6 deletion. Acta Ophthalmol Scand 79: 201-203.
66. Roh M, Zhang Y, Murakami Y, Thanos A, Lee SC, Vavvas DG, Benowitz LI, Miller JW. 2012. Etanercept, a widely used inhibitor of tumor necrosis factor-a (TNF-a), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS ONE 7: e40065.
67. Russo R, Cavaliere F, Watanabe C, Nucci C, Bagetta G, Corasaniti MT, Sakurada S, Morrone LA. 2008. 17b-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res 173: 583-590.
68. Sarfarazi M, Stoilov I. 2000. Molecular genetics of primary congenital glaucoma. Eye 14: 422-428.
69. Sarfarazi M, Akarsu NA, Hossain A, Turacli EM, Aktan GS, Barsoum-Homsy M, Chevrette L, Sayli SB. 1995. Assignment of a locus (GLC3A) for primary congenital glaucoma (Buphthalmos) to 2p21 and evidence for genetic heterogeneity. Genomics 30: 2171-2177.
70. Schlötzer-Schrehardt U. 2009. Molecular pathology of pseudoexfoliation syndrome/glaucoma—New insights from LOXL1 gene associations. Exp Eye Res 88: 776-785.
71. Schlötzer-Schrehardt U, Naumann GO. 1995. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study. Invest Ophthalmol Vis Sci 36: 1750-1764.
72. Sethi A, Mao W, Wordinger RJ, Clark AF. 2011. Transforming growth factorb induces extracellular matrix protein cross-linking lysyl oxidase (LOX) genes in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 52: 5240-5250.
73. Sharafieh R, Child AH, Khaw PT, Fleck B, Sarfarazi M. 2013. LTBP2 gene analysis in the GLC3C-linked family and 94 CYP1B1-negative cases with primary congenital glaucoma. Ophthalmic Genet 34: 14-20.
74. Sheffield VC, Stone EM, Alward WL, Drack AV, Johnson AT, Streb LM, Nichols BE. 1993. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat Genet 4: 47-50.
75. Sowers MR, Wilson AL, Kardia SR, Chu J, McConnell DS. 2006. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal. Am J Med 119: S44-S51.
76. Stein JD, Pasquale LR, Talwar N, Kim DS, Reed DM, Nan B, Kang JH, Wiggs JL, Richards JE. 2011. Geographic and climatic factors associated with exfoliation syndrome. Arch Ophthalmol 129: 1053-1060.
77. Stoilov I, Akarsu AN, Sarfarazi M. 1997. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 6: 641-647.
78. Stoilov IR, Sarfarazi M. 2002. The third genetic locus (GLC3C) for primary congenital glaucoma (PCG) maps to chromosome 14q24.3. Invest Ophthalmol Vis Sci 43: E3015.
79. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE, et al. 1997. Identification of a gene that causes primary open angle glaucoma. Science 275: 668-670.
80. Sud N, Wiseman DA, Black SM. 2010. Caveolin 1 is required for the activation of endothelial nitric oxide synthase in response to 17b-estradiol. Mol Endocrinol 24: 1637-1649.
81. Swiderski RE, Reiter RS, Nishimura DY, Alward WL, Kalenak JW, Searby CS, Stone EM, Sheffield VC, Lin JJ. 1999. Expression of the Mf1 gene in developing mouse hearts: Implication in the development of human congenital heart defects. Dev Dyn 216: 16-27.
82. Thorleifsson G, Magnusson KP, Sulem P, Walters GB, Gudbjartsson DF, Stefansson H, Jonsson T, Jonasdottir A, Jonasdottir A, Stefansdottir G, et al. 2007. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 317: 1397-1400.
83. Thorleifsson G, Walters GB, Hewitt AW, Masson G, Helgason A, DeWan A, Sigurdsson A, Jonasdottir A, Gudjonsson SA, Magnusson KP, et al. 2010. Common variants near CAV1 and CAV2 are associated with primary openangle glaucoma. Nat Genet 42: 906-909.
84. Toh T, Liew SH, MacKinnon JR, Hewitt AW, Poulsen JL, Spector TD, Gilbert CE, Craig JE, Hammond CJ, Mackey DA. 2005. Central corneal thickness is highly heritable: The twin eye studies. Invest Ophthalmol Vis Sci 46: 3718-3722.
85. Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y, et al. 2005. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res 11: 5793-5801.
86. Tsuchiya Y, Nakajima M, Yokoi T. 2005. Cytochrome P450mediated metabolism of estrogens and its regulation in human. Cancer Lett 227: 115-124.
87. Ueda J, Wentz-Hunter K, Yue BY. 2002. Distribution of myocilin and extracellular matrix components in the juxtacanalicular tissue of human eyes. Invest Ophthalmol Vis Sci 43: 1068-1076.
88. van Koolwijk LM, Ramdas WD, Ikram MK, Jansonius NM, Pasutto F, Hysi PG, Macgregor S, Janssen SF, Hewitt AW, Viswanathan AC, et al. 2012. Common genetic determinants of intraocular pressure and primary open-angle glaucoma. PLoS Genet 8: e1002611.
89. Vithana EN, Aung T, Khor CC, Cornes BK, Tay WT, Sim X, Lavanya R, Wu R, Zheng Y, Hibberd ML, et al. 2011. Collagen-related genes influence the glaucoma risk factor, central corneal thickness. Hum Mol Genet 20: 649-658.
90. Vithana EN, Khor CC, Qiao C, Nongpiur ME, George R, Chen LJ, Do T, Abu-Amero K, Huang CK, Low S, et al. 2012. Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma. Nat Genet 44: 1142-1146.
91. Volkmann BA, Zinkevich NS, Mustonen A, Schilter KF, Bosenko DV, Reis LM, Broeckel U, Link BA, Semina EV. 2011. Potential novel mechanism for Axenfeld-Rieger syndrome: Deletion of a distant region containing regulatory elements of PITX2. Invest Ophthalmol Vis Sci 52: 1450-1459.
92. Wang DY, Fan BJ, Canlas O, Tam PO, Ritch R, Lam DS, Fan DS, Pang CP. 2004. Absence of myocilin and optineurin mutations in a large Philippine family with juvenile onset primary open angle glaucoma. Mol Vis 10: 851-856.
93. Wang DY, Fan BJ, Chua JK, Tam PO, Leung CK, Lam DS, Pang CP. 2006. A genome-wide scan maps a novel juvenile-onset primary open-angle glaucoma locus to 15q. Invest Ophthalmol Vis Sci 47: 5315-5321.
94. Wiggs JL, Vollrath D. 2001. Molecular and clinical evaluation of a patient hemizygous for TIGR/MYOC. Arch Ophthalmol 119: 1674-1678.
95. Wiggs JL, Del Bono EA, Schuman JS, Hutchinson BT, Walton DS. 1995. Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21-q31. Ophthalmology 102: 1782-1789.
96. Wiggs JL, Allingham RR, Vollrath D, Jones KH, De La Paz M, Kern J, Patterson K, Babb VL, Del Bono EA, Broomer BW, et al. 1998. Prevalence of mutations in TIGR/Myocilin in patients with adult and juvenile primary open-angle glaucoma. Am J Hum Genet 63: 1549-1552.
97. Wiggs JL, Lynch S, Ynagi G, Maselli M, Auguste J, Del Bono EA, Olson LM, Haines JL. 2004. A genomewide scan identifies novel early-onset primary open-angle glaucoma loci on 9q22 and 20p12. Am J Hum Genet 74: 1314-1320.
98. Wiggs JL, Kang JH, Yaspan BL, Mirel DB, Laurie C, Crenshaw A, Brodeur W, Gogarten S, Olson LM, Abdrabou W, et al. 2011. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA. Hum Mol Genet 20: 4707-4713.
99. Wiggs JL, Kang JH, Yaspan BL, Mirel DB, Laurie C, Crenshaw A, Brodeur W, Gogarten S, Olson LM, Abdrabou W, et al. 2012. Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet 8: e1002654.
100. Wiggs JL, Hauser MA, Abdrabou W, Allingham RR, Budenz DL, Delbono E, Friedman DS, Kang JH, Gaasterland D, Gaasterland T, et al. 2013a. The NEIGHBOR Consortium primary open-angle glaucoma genome-wide association study: Rationale, study design, and clinical variables. J Glaucoma 22: 517-525.
101. Wiggs JL, Howell GR, Linkroum K, Abdrabou W, Hodges E, Braine CE, Pasquale LR, Hannon GJ, Haines JL, John SW. 2013b. Variations in COL15A1 and COL18A1 influence age of onset of primary open angle glaucoma. Clin Genet 84: 167-174.
102. Winnier GE, Kume T, Deng K, Rogers R, Bundy J, Raines C, Walter MA, Hogan BL, Conway SJ. 1999. Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular development revealed by nonallelic noncomplementation of null alleles. Dev Biol 213: 418-431.
103. Yam GH, Gaplovska-Kysela K, Zuber C, Roth J. 2007. Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis. Invest Ophthalmol Vis Sci 48: 1683-1690.
104. Ying H, Yue BY. 2012. Cellular and molecular biology of optineurin. Int Rev Cell Mol Biol 294: 223-258.
105. Zhou X, Li F, Ge J, Sarkisian SR, Tomita H, Zaharia A, Chodosh J, Cao W. 2007. Retinal ganglion cell protection by 17-b-estradiol in a mouse model of inherited glaucoma. Dev Neurobiol 67: 603-616.
106. Zhou YY, Zhao Y, Mirza MK, Huang JH, Potula HHSK, Vogel SM, Brovkovych V, Yuan JXJ, Wharton J, Malik AB. 2009. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest 119: 2009-2018.
107. Zode GS, Clark AF, Wordinger RJ. 2009. Bone morphogenetic protein 4 inhibits TGF-b2 stimulation of extracellular matrix proteins in optic nerve head cells: Role of gremlin in ECM modulation. Glia 57: 755-766.
108. Zode GS, Kuehn MH, Nishimura DY, Searby CC, Mohan K, Grozdanic SD, Bugge K, Anderson MG, Clark AF, Stone EM, et al. 2011. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J Clin Invest 121: 3542-3553.
109. Zode GS, Bugge KE, Mohan K, Grozdanic SD, Peters JC, Koehn DR, Anderson MG, Kardon RH, Stone EM, Sheffield VC. 2012. Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma. Invest Ophthalmol Vis Sci 53: 1557-1565.